Medical cannabis sales in Connecticut in April decreased for the first time since adult-use sales commenced in the state, according to state data outlined by CT Insider. Medical cannabis sales in April totaled $11.4 million, down from $12.6 million in March, but were still higher than adult-use sales in April, which reached $10.2 million.
Adult-use cannabis sales in Connecticut commenced in January and totaled $5.1 million, while medical cannabis sales reached just over $8 million. In February, adult-use sales were just over $7 million, while medical cannabis sales totaled $11.4 million. In March, adult-use sales climbed to about $9.6 million, with medical sales totaling about $12.6 million.
The price of medical cannabis since the launch of adult-use sales has remained stable, with an average product price of $35.68 in January, $36.11 in February, $37.06 in March, and $36.51 in April, according to state data. Adult-use prices have declined since the $44.61 average seen during the January market launch. In February, the average price was $41.82; $40.69 in March; and $39.58 in April.
Despite the strong medical cannabis sales, patient counts are on the decline in the state. In January, there were 48,896 registered medical cannabis patients, compared to 46,048 in April.
Get daily cannabis business news updates. Subscribe
